Becton, Dickinson and Company (NYSE:BDX) authorized to pursue a plan to separate BD’s Biosciences and Diagnostic Solutions ...

Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to 30% ...

Pen Needles Market Insight BURLINGAME, CA, UNITED STATES, February 5, 2025 /EINPresswire / -- The Pen Needles Market Report is the result of e ...

Becton Dickinson plans to separate its Biosciences ... syringes, and advanced needle technologies. Connected Care includes BD’s Medication Management Solutions and Advanced Patient Monitoring ...

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled ...

Company Delivers Revenue, Margin and Earnings Ahead of its Expectations Revenue of $5.2 billion increased 9.8% as reported, 9.6% currency-neutral and 3.9% organic ...

Becton, Dickinson, headquartered in Franklin Lakes ... $10 million to enhance manufacturing capacity by initiating new needle and syringe production at the plants in Connecticut and Nebraska.

Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.43 in the first ...

Becton Dickinson is expanding production of medical ... has already added new needle and syringe production lines at its plants in Connecticut and Nebraska. One of those lines is fully operational ...

Embecta Corp. ("embecta" or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month period ...

Disclosure: Both authors are employed by BD (Becton Dickinson & Co.) and own shares ... Intradermal delivery using standard needles and syringes is difficult to accomplish and requires extensive ...